Arkolith/Insider Trading/NXL/Form 4

Owens David

Chief Medical Officer, DirectorNexalin Technology, Inc. (NXL) · full profile →Form 4 · filed Aug 15, 2024
Net Buying
Open-Market Buys
$950
Open-Market Sells
$0
Net Open-Market Flow
$950
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2024Buy(P)1K$0.95$950148K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-24-005573) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML